Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Eskisehir Osmangazi University, Eskisehir, Turkey.

Survival: monthsCountry:Turkey
Toxiciy Grade:4City/State/Province:Eskisehir
Treatments:ChemotherapyHospital:Eskisehir Osmangazi University
Drugs:Journal:Link
Date:Jul 2015

Description:

Patients:
This study involved malignant pleural mesothelioma patients who were separated into two different treatment groups. Group A consisted of 116 patients, 58 of whom were male, with an average patient age of 60.7 years. Group B had 30 patients, 14 of whom were male, with an average patient age of 60.8 years.

Treatment:
Patients in group A received chemotherapy with cisplatin/carboplatin and pemetrexed.

Patients in group B received chemotherapy with cisplatin/carboplatin and gemcitabine.

Toxicities:
The most severe toxicities in group A were grade 3-4 and included neutropenia, nausea/vomiting, and nerve toxicity.

The most severe toxicities in group B were grade 3-4 and included neutropenia and nausea/vomiting.

Results:
The median overall survival times in group A and B were both 11.0 months.

Correspondence: Dr. Guntulu Ak; email: [email protected]



Back